NEW YORK, March 26 - CombiMatrix has withdrawn its planned initial public offering on Monday, but a previously announced move that would give the firm its own Nasdaq listing is still on.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.
Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.
In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.
The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.